Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-1991 | 12-1990 | 12-1989 | 12-1988 | |
| Cash Flows From Operating Activities | ||||
| Net Income | N/A | -3,298 | -2,656 | -954 |
| Depreciation Amortization | N/A | 325 | 193 | 13 |
| Other Working Capital | N/A | 951 | -281 | 7 |
| Other Operating Activity | 0 | -1,195 | -534 | 0 |
| Operating Cash Flow | $N/A | $-3,218 | $-3,278 | $-934 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | N/A | -1,651 | -434 | -488 |
| Other Investing Activity | 0 | -1,138 | -1,958 | 0 |
| Investing Cash Flow | $N/A | $-2,789 | $-2,392 | $-488 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 0 | 15,578 | 10,327 | 6,361 |
| Financing Cash Flow | $N/A | $15,578 | $10,327 | $6,361 |
| Beginning Cash Position | N/A | 9,595 | 4,939 | N/A |
| End Cash Position | N/A | 19,167 | 9,595 | 4,939 |
| Net Cash Flow | $N/A | $9,572 | $4,657 | $4,939 |
| Free Cash Flow | ||||
| Operating Cash Flow | N/A | -3,218 | -3,278 | -934 |
| Free Cash Flow | 0 | -3,218 | -3,278 | -934 |